Prostacyclin (PGI) Receptor Binding and Cyclic AMP Synthesis Activities of PGI_1 Analogues, SM-10906 and Its Methyl Ester, SM-10902,in Mastocytoma P-815 Cells
スポンサーリンク
概要
- 論文の詳細を見る
The prostacyclin I_1 (PGI_1) analogue, SM-10906 and its methyl ester, SM-10902,have been compared with the PGI_2 analogue, iloprost, with respect to binding to the PGI_2 receptor, stimulation of adenylate cyclase activity and inhibition of thrombin-induced Ca^<2+> mobilization in mastocytoma P-815 cells. SM-10906 displaced [^3H]iloprost binding to the membrane fraction, the IC_<50> value being 20 nM, but showed very low affinity for the prostaglandin E (PGE) receptor. SM-10906 dose-dependently stimulated GTP-dependent adenylate cyclase activity in the membrane fraction, the EC_<50> value being 35 nM. Furthermore, SM-10906 prevented a thrombin-induced increase in the intracellular Ca^<2+> concentration, the IC_<50> value being 100 nM. These IC_<50> and EC_<50> values are much lower than those of SM-10902. These results demonstrate that SM-10906,a stable PGI_1 derivative, is an agonist for the [^3H]iloprost-binding (PGI_2) receptor, and that it prevents thrombin-induced Ca^<2+> mobilization through stimulation of the adenylate cyclase system in mastocytoma cells. On the other hand, a methyl ester derivative of PGI_1,SM-10902,was inactive in the binding assay, but it seems to be a partial agonist for adenylate cyclase activity.
- 社団法人日本薬学会の論文
- 1994-01-15
著者
-
根岸 学
京大 薬
-
市川 厚
京大 薬
-
市川 厚
Department of Health Chemistry, Faculty of Pharmaceutical Sciences, Kyoto University
-
岡 美智子
Department of Physiological Chemistry, Faculty of Pharmaceutical Sciences, Kyoto University
-
根岸 学
Department of Physiological Chemistry, Faculty of Pharmaceutical Sciences, Kyoto University
-
山本 貴昭
Research Laboratories, Sumitomo Pharmaceuticals Co., Ltd.,
-
佐藤 公彦
Research Laboratories, Sumitomo Pharmaceuticals Co., Ltd.,
-
廣橋 敏之
Research Laboratories, Sumitomo Pharmaceuticals Co., Ltd.,
-
岡 美智子
Department Of Physiological Chemistry Faculty Of Pharmaceutical Sciences Kyoto University
-
佐藤 公彦
Research Laboratories Sumitomo Pharmaceuticals Co. Ltd.
-
市川 厚
Department Of Health Chemistry Faculty Of Pharmaceutical Sciences Kyoto University
-
山本 貴昭
Research Laboratories Sumitomo Pharmaceuticals Co. Ltd.
-
廣橋 敏之
Research Laboratories Sumitomo Pharmaceuticals Co. Ltd.
関連論文
- 89 プロスタサイクリン受容体タンパク質の構造研究 : 光親和性標識法による分子量の同定(口頭発表の部)
- Effect of Hydrocortisone on Histidine Decarboxylase Activity in Rat Stomach
- cAMP産生系に共役する2種のプロスタグランジンE受容体サブタイプEP2・EP4の機能的相違
- プロスタグランジンE受容体サブタイプEP2・EP4の脱感作現象及びアゴニストの代謝不活性化に対する感受性の相違
- アゴニスト非依存的Gi活性とアゴニスト依存的Gs活性における3つのプロスタグランジンE受容体EP3アイソフォームの多様性
- シクロペンテノン型プロスタグランジンの細胞内局在と遺伝子誘導
- △^プロスタグランジンJ_2による小胞体内シャペロンBiPの遺伝子誘導の調節機構
- プロスタグランジンE受容体EP3BによるRhoを介した神経突起の退縮
- Prostacyclin (PGI) Receptor Binding and Cyclic AMP Synthesis Activities of PGI_1 Analogues, SM-10906 and Its Methyl Ester, SM-10902,in Mastocytoma P-815 Cells
- プロスタグランジン受容体
- Secretion of Poly(3-hydroxybutyrate) Depolymerase by Alcaligenes faecalis T1
- 偽妊娠・妊娠マウス子宮におけるプロスタグランジンE受容体サブタイプの発現パターン
- プロスタノイド受容体の分子構造と機能
- プロスタグランジン受容体の構造と機能 : 創薬への考察
- Characterization of a Lipophilic Prodrug of 5-Fluorouracil with a Cholesterol Promoiety and Its Application to Liposomes
- Studies on the Synthesis of COmpounds Related to Adenosine 3', 5'-Cyclic Phosphate. IX. Synthesis and Cytotoxic Effect of Adenosine 3', 5'-Cyclic Alkylphosphoramidates